Search COVID-19 Rapid Resource Center or explore resources sorted by Category or Content Type.


Treatment for Severe Coronavirus Disease 2019 With the Seraph-100 Microbind Affinity Blood Filter

From Critical Care Explorations

The authors sought to determine whether Seraph-100 (Exthera Medical Corporation, Martinez, CA) treatment provides clinical benefit for severe coronavirus disease 2019 cases that require mechanical ventilation and vasopressor support.

Authors:

Olson SW, Oliver JD, Collen J, et al.  


Estimated Time: 12:23

Categories: Disaster, Pulmonary,
Content Type: Articles,